These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


644 related items for PubMed ID: 19938143

  • 1. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 2. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K, Davidson BR, Patch DW, Burroughs AK.
    Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
    [Abstract] [Full Text] [Related]

  • 3. Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
    Manousou P, Cholongitas E, Samonakis D, Tsochatzis E, Corbani A, Dhillon AP, Davidson J, Rodríguez-Perálvarez M, Patch D, O'Beirne J, Thorburn D, Luong T, Rolles K, Davidson B, McCormick PA, Hayes P, Burroughs AK.
    Gut; 2014 Jun; 63(6):1005-13. PubMed ID: 24131637
    [Abstract] [Full Text] [Related]

  • 4. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 6. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
    Manousou P, Dhillon AP, Isgro G, Calvaruso V, Luong TV, Tsochatzis E, Xirouchakis E, Kalambokis G, Cross TJ, Rolando N, O'Beirne J, Patch D, Thornburn D, Burroughs AK.
    Liver Transpl; 2011 Feb; 17(2):178-88. PubMed ID: 21280191
    [Abstract] [Full Text] [Related]

  • 7. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
    Margarit C, Bilbao I, Castells L, Lopez I, Pou L, Allende E, Escartin A.
    Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
    [Abstract] [Full Text] [Related]

  • 8. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia A, Triantos CK, Mela M, Manousou P, Senzolo M, Dhillon AP, Patch D, Burroughs AK.
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [Abstract] [Full Text] [Related]

  • 9. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [Abstract] [Full Text] [Related]

  • 10. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 11. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 12. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW, Langnas AN.
    Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
    [Abstract] [Full Text] [Related]

  • 13. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 14. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F.
    Transplantation; 2008 Dec 27; 86(12):1666-71. PubMed ID: 19104402
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient.
    Kalambokis G, Manousou P, Samonakis D, Grillo F, Dhillon AP, Patch D, O'Beirne J, Rolles K, Burroughs AK.
    Transpl Int; 2009 Feb 27; 22(2):172-81. PubMed ID: 18786149
    [Abstract] [Full Text] [Related]

  • 16. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
    Martin P, Busuttil RW, Goldstein RM, Crippin JS, Klintmalm GB, Fitzsimmons WE, Uleman C.
    Liver Transpl; 2004 Oct 27; 10(10):1258-62. PubMed ID: 15376310
    [Abstract] [Full Text] [Related]

  • 17. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation.
    Di Benedetto F, Di Sandro S, De Ruvo N, Montalti R, Ballarin R, Guerrini GP, Spaggiari M, Guaraldi G, Gerunda G.
    Transplantation; 2010 Mar 27; 89(6):733-8. PubMed ID: 20048692
    [Abstract] [Full Text] [Related]

  • 18. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar 27; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

  • 19. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S, Hunt DR, Stone MA, McClune A, Tong MJ.
    Liver Transpl; 2010 Jun 27; 16(6):748-59. PubMed ID: 20517909
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May 27; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.